This is a condition that affects both your muscles and your skin. It causes muscle weakness, especially in the hips and shoulders, and a specific type of rash. It can happen at any age, but it's more common in adults. Doctors need to diagnose this condition carefully.
Every report comes from a Lived member, sent anonymously.
Have you tried Prednisone for Dermatomyositis?
Dermatomyositis is a rare autoimmune disease in which the immune system inflames the muscles and the skin. It typically causes two problems together: weakness in the large muscles closest to the trunk, such as the hips, thighs, shoulders, upper arms and neck, and a distinctive rash. The weakness shows up as trouble climbing stairs, getting up from a chair or the floor, lifting the arms to reach a shelf or raising the head from a pillow. It may build over weeks or months or come on more suddenly, and some people also have aching muscles and tiredness. The rash is usually purplish or red. Typical places are the upper eyelids, the knuckles, elbows and knees, and the face, neck, upper chest and back, and it can itch. The rash often appears before any weakness, and in some people it is the only obvious sign, a form called clinically amyopathic dermatomyositis. On darker skin it can be harder to notice. Dermatomyositis can also affect the lungs, the muscles used for swallowing and, less often, the heart, so it is treated as a whole-body condition rather than a skin or muscle problem alone. It belongs to a group of inflammatory muscle diseases (inflammatory myopathies) that also includes polymyositis, which causes similar weakness without the rash.
The exact cause is not known. In dermatomyositis, the immune system damages small blood vessels in the muscles and skin, which leads to inflammation and weakness. Researchers think inherited susceptibility and environmental factors combine to set this off, but no single trigger explains most cases. It can begin at any age, but it most often starts in children between about 5 and 15 and in adults between about 40 and 60. Women are affected about twice as often as men. In adults, dermatomyositis is linked to cancer. A cancer is more likely to be found in the three years before and after the disease begins, and in some people the dermatomyositis appears to be the immune system's reaction to a tumor. This link does not apply to the childhood form. Less often, a medicine sets it off. Hydroxyurea (a medicine for some blood disorders), immune checkpoint inhibitors (a type of cancer immunotherapy) and statins (cholesterol medicines) are among those reported. Sunlight is not thought to cause the disease on its own, but sun exposure is associated with flares of the rash and sometimes of the muscle disease.
Diagnosis starts with the pattern a clinician can see and measure: the typical rash, and weakness in the muscles near the trunk on examination. Because the rash is so characteristic, it carries much of the diagnosis, and a skin biopsy (a small sample of skin) can support it. Blood tests look for raised muscle enzymes such as creatine kinase (CK), which leaks out of damaged muscle. A high level points to active muscle inflammation, although it can be normal in people whose disease mainly affects the skin. Tests for myositis antibodies, immune proteins tied to particular forms of the disease, help confirm the diagnosis and show which complications are more likely. For example, anti-MDA5 and anti-synthetase antibodies are linked to lung disease, and anti-TIF1-gamma and anti-NXP2 antibodies to cancer in adults. An MRI scan can show which muscles are inflamed, electromyography (EMG) tests the electrical activity of muscles, and a muscle biopsy may be needed when the picture is unclear. The assessment also looks beyond muscle and skin. Breathing tests and a chest X-ray or CT scan check for interstitial lung disease (inflammation and scarring of the lung tissue), a swallowing assessment may be arranged, and an ECG (electrocardiogram, a tracing of the heart's electrical activity) or other heart tests look for heart involvement. Adults are also checked for cancer. International guidance from 2023 sorts people into standard, moderate or high cancer risk based on their form of the disease, antibodies and other features, and matches the screening to that risk, from basic blood tests and a chest X-ray up to CT scans and sometimes endoscopy or a PET-CT scan (a whole-body scan that highlights unusually active tissue). Screening is commonly repeated during the first few years. Children are not routinely screened for cancer because the childhood form is not linked to it.
There is no cure, but treatment can calm the inflammation, restore strength, settle the rash and protect the lungs and other organs. It is usually led by a rheumatologist, often working with a dermatologist, and is matched to how severe the disease is and which organs are involved. The first step is usually a high dose of a corticosteroid such as prednisone, which acts quickly against inflammation. The dose is lowered gradually as strength returns. Because long-term steroids bring problems such as bone thinning, an immune-suppressing medicine is usually added early to keep the disease controlled while the steroid comes down. Options include methotrexate, azathioprine, mycophenolate and tacrolimus, and for children, methotrexate with a steroid is the usual first choice. These medicines need regular blood test monitoring. When the disease stays active or is severe, other treatments are added. Intravenous immune globulin (IVIG) is made from antibodies pooled from donated blood and is given as an infusion, usually every four weeks. One IVIG product, Octagam 10%, is approved in the US for adults with dermatomyositis. In a 16-week trial, 79% of adults on IVIG improved at least slightly, compared with 44% on placebo. IVIG can cause blood clots, so a person's clotting risk is weighed before it is used. Rituximab (an antibody infusion that removes certain immune cells) and cyclophosphamide (a strong immune-suppressing drug also used in chemotherapy) are further options for hard-to-control disease or serious lung involvement, and lung disease is managed together with a lung specialist. Daily care matters as well. A supervised exercise program with a physical or occupational therapist is safe during treatment and helps rebuild strength and everyday function. Avoiding strong sun and using a high-protection broad-spectrum sunscreen can lower the chance of flares. Speech and swallowing therapy helps when swallowing is affected. If a cancer is found, treating it can improve the dermatomyositis too.
Dermatomyositis is usually a long-term condition, and its course varies widely. Symptoms improve with treatment for many people, and in some, especially children, they go away completely. Others have flares, lasting weakness or a rash that persists after the muscles have recovered, and they need treatment for years. The rash can itch enough to disturb sleep, and as it fades it may leave darker, lighter or thinned patches of skin. Strength comes back gradually. The first months involve frequent visits and blood tests while the steroid dose comes down and other medicines are adjusted. Ongoing follow-up usually includes strength checks, muscle enzyme tests, breathing tests for people at risk of lung disease, a bone health assessment and, for adults, cancer screening over the first few years. Fatigue, steroid side effects and the work of managing a long-term illness can affect mood, and attention to mental wellbeing is part of good care. The childhood form differs in several ways. Remission is achievable for many children, and specialist guidance aims for inactive disease within about a year of starting treatment. Children are more prone to calcinosis, hard calcium deposits under the skin, most often at the elbows, knees and buttocks, which can break through the skin and form sores that are slow to heal. They are also more prone to inflammation of small blood vessels (vasculitis), which can affect the skin and gut. Early, effective treatment lowers the risk of calcinosis, which is why care is led by pediatric specialists. For anyone planning a pregnancy, the advice is to conceive while the disease is well controlled and to plan care with specialists, because pregnancy carries higher risks and flares can follow delivery. Some treatments, including methotrexate, mycophenolate and cyclophosphamide, can harm a developing baby, so anyone who could become pregnant needs reliable contraception while taking them and a medicine review before trying to conceive. Men taking these medicines should also ask about the plan before fathering a child. In adults, the long-term outlook depends a great deal on whether the lungs are involved and whether a cancer is present. Lung disease that progresses quickly, which can happen with anti-MDA5 antibodies even when the muscles are barely affected, is the most serious early threat.
See a doctor if you notice weakness in your hips, thighs, shoulders or neck that makes everyday movements harder, or a purplish or red rash on your eyelids, knuckles or upper body, especially the two together. Because dermatomyositis is rare, asking for a referral to a rheumatologist or dermatologist with myositis experience can shorten the path to diagnosis, and earlier treatment is linked to better outcomes in children. If you already have the condition, contact your care team about a returning rash, renewed weakness or troublesome treatment side effects. Call your care team right away for new or worsening shortness of breath or a new dry cough, trouble swallowing or choking and coughing when you eat or drink, or weakness that is getting worse quickly. These can signal lung disease or weakness of the breathing and swallowing muscles, which need prompt treatment. Severe trouble breathing, such as struggling to breathe at rest, is an emergency: call 911.
Last reviewed • Oct 2026
Educational content, not medical advice.
Share what living with Dermatomyositis is like, what's helped you, or ask the community a question.